FAKTOR-OPTIONSSCHEIN - AMGEN | Market Closed - Börse Stuttgart 15:42:19 2024-07-05 EDT | ||
| 4.25 EUR | +3.16% |
|
| Current month | -3.85% | ||
| 3 months | +53.99% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-05 | 4.25 | +3.16% |
| 24-07-04 | 4.12 | -0.96% |
| 24-07-03 | 4.16 | -4.59% |
| 24-07-02 | 4.36 | 0.00% |
| 24-07-01 | 4.36 | -1.36% |
Delayed Quote Börse Stuttgart
Last update July 05, 2024 at 03:42 pm
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Morgan Stanley |
| WKN | MB0LCT |
| ISIN | DE000MB0LCT5 |
| Date issued | 2022-11-14 |
| Strike | 247.6 $ |
| Maturity | Unlimited |
| Parity | 13.7 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.96 € |
|---|---|
| Lowest since issue | 1.58 € |
| Spread | 0.02 € |
| Spread % | 0.47% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.9
USD
Average target price
316.4
USD
Spread / Average Target
+1.79%
- Stock Market
- Certificates
- Certificat
